GSB Podium Advisors, LLC
Follow13F filer, CIK 1536600, New York, NY
GSB Podium Advisors, LLC reported $94,000 across 1 holding for the quarter ended 2013-12-31, in a 13F-HR filed 2014-02-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001144204-14-009805
- Period
- 2013-12-31
- Reported value
- $94K
- Holdings
- 1
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 7
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| APOLLO INVT CORPnew | +11,077 | $94K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| PPGexited | -1,666 | -$278K |
| NFLXexited | -829 | -$256K |
| ULTAexited | -1,958 | -$234K |
| CDEexited | -13,039 | -$157K |
| PENNEY J C INCexited | -14,655 | -$129K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2013
Share positions as resolved from 13F-HR 0001144204-14-009805, largest first. % of portfolio is the value over $94,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| APOLLO INVT CORPAPOLLO INVT CORP | 11,077 | $94K | 100% | new |
Sold out in Q4 2013
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| PPGPPG INDS INC | 1,666 | $278K | shares |
| NFLXNETFLIX INC. | 829 | $256K | shares |
| ULTAULTA BEAUTY INC | 1,958 | $234K | shares |
| CDECOEUR MNG INC | 13,039 | $157K | shares |
| PENNEY J C INCPENNEY J C INC | 14,655 | $129K | shares |
| QLOGIC CORPQLOGIC CORP | 10,822 | $118K | shares |
| ARENA PHARMACEUTICALS INC.ARENA PHARMACEUTICALS INC. | 10,500 | $55K | shares |
How Q4 2013 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001144204-14-009805 | base | 2014-02-14 | acceptance time not in the bulk data set |